Impact of the British Lung Foundation Active Steps service on patient reported outcomes: concurrent cohort study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021
Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021
Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs) Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006 Source: Eur Respir J 2008; 31: 29-35 Year: 2008
Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020
Development of the Birmingham Lung Improvement Studies (BLISS) prognostic score for COPD patients in primary care: data from the Birmingham COPD cohort Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care Year: 2019
The primary care routine data registry BeoNet: First pilot phase results for COPD research Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015
Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF) Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study Source: Eur Respir J 2013; 41: 571-577 Year: 2013
Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK) Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013
Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014
Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019
The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018
Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
Registries: roles, objectives and registry data study outcomes Source: Eur Respir Monogr 2019; 85: 150-158 Year: 2019
Patient demographics and clinical characteristics in the UK Salford Lung Study (SLS COPD) and the European ACCESS study Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017
The effect of changes in quality of life in patients with lung cancer in the observation period (European Organization for Research and treatment of Cancer) EORTC QLQ-C 30 results of the evaluation and follow-up (AKAYAK-1 project) Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013